drugset / Trial / NCT00405730

Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo

NCT00405730

Phase 3 Completed 227 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the safety and efficacy of Nepafenac 1 mg/ml Eye Drops, Suspension, compared to Placebo and Ketorolac Trometamol 5 mg/ml Eye Drops, Solution for the prevention and treatment of ocular inflammation and ocular pain after cataract extraction with IOL implantation

Timeline

Start
2005-11
Primary completion
2006-07
Completion
2006-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketorolac Other / unclassified 5 mg/ml Other
Subject Nepafenac Other / unclassified 1 mg/ml Other

Indications